Silvercrest Asset Management Group LLC Exagen Inc. Transaction History
Silvercrest Asset Management Group LLC
- $14.3 Billion
- Q3 2024
A detailed history of Silvercrest Asset Management Group LLC transactions in Exagen Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 540,888 shares of XGN stock, worth $2.79 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
540,888
Previous 544,877
0.73%
Holding current value
$2.79 Million
Previous $991,000
68.62%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding XGN
# of Institutions
38Shares Held
6.41MCall Options Held
4.5KPut Options Held
400-
Rtw Investments, LP New York, NY1.51MShares$7.79 Million0.07% of portfolio
-
Cowen And Company, LLC891KShares$4.59 Million0.07% of portfolio
-
Stonepine Capital Management, LLC Bend, OR534KShares$2.75 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$2.53 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT490KShares$2.52 Million0.01% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $83.7M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...